Rani Therapeutics Holdings, Inc. Class A Share Price

Rani Therapeutics Holdings, Inc. Class A Share Price

NASDAQ: RANI | Micro Cap
$0.60
-$0.01 (-1.24%) Last updated on 30 Oct, 2026 | 22:31 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Rani Therapeutics Holdings, Inc. Class A Stock Performance

Open
$0.60
Prev. Close
$0.60
Circuit Range
N/A
Day Range
$0.59 - $0.60
Year Range
$0.58 - $2.63
Volume
3,289
Average Traded
$0.60

Rani Therapeutics Holdings, Inc. Class A Share Price Today

As of 30 October 2026, Rani Therapeutics Holdings, Inc. Class A's share price is $0.60. The stock opened at $0.60, compared to its previous close of $0.60. During today's trading session, Rani Therapeutics Holdings, Inc. Class A's share price traded between $0.59 and $0.60, with an average price of $0.60. Over the past 52 weeks, the stock has recorded a high of $2.63 and a low of $0.58. In terms of performance, Rani Therapeutics Holdings, Inc. Class A's share price has declined by 32.58% over the last six months and is down 72.63% on a year-on-year basis.

Rani Therapeutics Holdings, Inc. Class A Share Price Chart

Line chart of the Rani Therapeutics Holdings, Inc. Class A price trend over the selected period. The price fell overall, ranging from 0.59 to 0.60, ending at 0.60.
$0.59$0.60
L
Show Current Price
H

Rani Therapeutics Holdings, Inc. Class A Stock Fundamentals & Key Indicators

Market Cap
$39464.54
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.26
Revenue (TTM)
$1.63B
Return On Equity (TTM)
-76.82%
Profit Margin
-1820.25%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-36.60%

Rani Therapeutics Holdings, Inc. Class A Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$1.46$1.71$1.71
Net Profit-$5.41-$10.31-$7.03-$7.39
Net Profit MarginN/A-706.16%-411.11%-432.16%
Income ChangeN/A-90.57%31.81%-5.12%

Rani Therapeutics Holdings, Inc. Class A Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$1.03$1.63
Net Profit-$30.59-$33.97-$30.02-$29.67
Net Profit MarginN/AN/A-2914.56%-1820.25%
Income ChangeN/A-11.05%11.63%1.17%

About Rani Therapeutics Holdings, Inc. Class A

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Rani Therapeutics Holdings, Inc. Class A Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.81
$0.60
-24.94%
Sep 2026
$0.85
$0.79
-6.81%
Aug 2026
$0.80
$0.85
+9.51%
Jul 2026
$0.77
$0.78
+2.23%
Jun 2026
$0.94
$0.76
-19.98%
May 2026
$0.91
$0.95
+7.46%
Apr 2026
$0.73
$0.89
+21.57%
Mar 2026
$1.34
$0.73
-47.25%
Feb 2026
$1.20
$1.38
+15.00%
Jan 2026
$1.37
$1.20
-11.44%
Dec 2025
$1.55
$1.35
-14.78%
Nov 2025
$2.42
$1.59
-27.06%

RANI Share Price FAQs